Literature DB >> 20489138

Epigenetic regulation of myofibroblast differentiation by DNA methylation.

Biao Hu1, Mehrnaz Gharaee-Kermani, Zhe Wu, Sem H Phan.   

Abstract

DNA methylation, a key mechanism of repressing gene expression, is of particular relevance in controlling development and cell differentiation. We analyzed the extent and regulation of DNA methylation of the alpha-smooth muscle actin (alpha-SMA) gene to elucidate its potential role in myofibroblast differentiation. These experiments revealed the presence of three CpG islands that were methylated at different levels in fibroblasts, myofibroblasts, and alveolar epithelial type II cells. Coordinately, these cells expressed low, high, or no alpha-SMA, respectively. In addition, inhibition of DNA methyltransferase activity or knock down of DNA methyltransferase using specific small interfering RNA caused significant induction of alpha-SMA in fibroblasts. In contrast, induced overexpression of DNA methyltransferase suppressed alpha-SMA gene expression. Transforming growth factor beta induced myofibroblast differentiation was enhanced or suppressed by knockdown or overexpression of DNA methyltransferase, respectively. Finally, in vitro DNA methylation of the alpha-SMA promoter suppressed its activity. These findings suggest that DNA methylation mediated by DNA methyltransferase is an important mechanism regulating the alpha-SMA gene expression during myofibroblast differentiation.

Mesh:

Substances:

Year:  2010        PMID: 20489138      PMCID: PMC2893647          DOI: 10.2353/ajpath.2010.090999

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.

Authors:  P D Zamore; T Tuschl; P A Sharp; D P Bartel
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

Review 2.  Evaluation of an inhibitor of DNA methylation, 5-aza-2'-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy.

Authors:  R L Momparler; N Eliopoulos; J Ayoub
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

3.  De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation.

Authors:  Jonathan E Dodge; Bernard H Ramsahoye; Z Galen Wo; Masaki Okano; En Li
Journal:  Gene       Date:  2002-05-01       Impact factor: 3.688

Review 4.  The myofibroblast in pulmonary fibrosis.

Authors:  Sem H Phan
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

5.  DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium.

Authors:  Cedric Plachot; Sophie A Lelièvre
Journal:  Exp Cell Res       Date:  2004-08-01       Impact factor: 3.905

6.  FIZZ1 stimulation of myofibroblast differentiation.

Authors:  Tianju Liu; Saravana M Dhanasekaran; Hong Jin; Biao Hu; Scott A Tomlins; Arul M Chinnaiyan; Sem H Phan
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

8.  Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression.

Authors:  Biao Hu; Zhe Wu; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04-17       Impact factor: 6.914

9.  Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins.

Authors:  Meena S Kumar; Jennifer A Hendrix; A Daniel Johnson; Gary K Owens
Journal:  Circ Res       Date:  2003-03-27       Impact factor: 17.367

Review 10.  5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.

Authors:  Judith K Christman
Journal:  Oncogene       Date:  2002-08-12       Impact factor: 9.867

View more
  57 in total

Review 1.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Marco Prunotto; Alexis Desmoulière; John Varga; Olivier De Wever; Marc Mareel; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2012-03-02       Impact factor: 4.307

2.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

Review 3.  Epigenetics in lung fibrosis: from pathobiology to treatment perspective.

Authors:  Britney A Helling; Ivana V Yang
Journal:  Curr Opin Pulm Med       Date:  2015-09       Impact factor: 3.155

Review 4.  Epigenomics of idiopathic pulmonary fibrosis.

Authors:  Ivana V Yang
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

Review 5.  DNA methylation regulated gene expression in organ fibrosis.

Authors:  Xiangyu Zhang; Min Hu; Xing Lyu; Chun Li; Victor J Thannickal; Yan Y Sanders
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-10       Impact factor: 5.187

Review 6.  The reactive stroma microenvironment and prostate cancer progression.

Authors:  David A Barron; David R Rowley
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

Review 7.  Genesis of the myofibroblast in lung injury and fibrosis.

Authors:  Sem H Phan
Journal:  Proc Am Thorac Soc       Date:  2012-07

8.  IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER.

Authors:  David A Schwartz
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 9.  Bone marrow cells as precursors of the tumor stroma.

Authors:  Daniel L Worthley; Yiling Si; Michael Quante; Michael Churchill; Siddhartha Mukherjee; Timothy C Wang
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

10.  miR-145 regulates myofibroblast differentiation and lung fibrosis.

Authors:  Shanzhong Yang; Huachun Cui; Na Xie; Mert Icyuz; Sami Banerjee; Veena B Antony; Edward Abraham; Victor J Thannickal; Gang Liu
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.